These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3806401)

  • 1. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
    Ringdahl B; Jenden DJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):370-5. PubMed ID: 3806401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
    Ringdahl B; Katz ED; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
    Ringdahl B; Resul B; Ehlert FJ; Jenden DJ; Dahlbom R
    Mol Pharmacol; 1984 Sep; 26(2):170-9. PubMed ID: 6332977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmuscarinic neurotoxicity of oxotremorine.
    Witkin JM; Alvarado-Garcia R; Lee MA; Witkin KM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):34-41. PubMed ID: 3572794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an alkylating derivative of oxotremorine (BM 123A) on heart rate, muscarinic receptors and adenylate cyclase activity in the rabbit myocardium.
    Ehlert FJ
    J Pharmacol Exp Ther; 1987 Jun; 241(3):804-11. PubMed ID: 3598904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists.
    Ringdahl B
    J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tertiary 3- and 4-haloalkylamine analogues of oxotremorine as prodrugs of potent muscarinic agonists.
    Ringdahl B; Roch M; Jenden DJ
    J Med Chem; 1988 Jan; 31(1):160-4. PubMed ID: 3336014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.
    Engström C; Undén A; Ladinsky H; Consolo S; Bartfai T
    Psychopharmacology (Berl); 1987; 91(2):161-7. PubMed ID: 3107028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral mediation of hypothermia, tremor and salivation induced by muscarinic agonists in mice.
    Sánchez C; Meier E
    Pharmacol Toxicol; 1993; 72(4-5):262-7. PubMed ID: 8372044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of brain acetylcholine concentration by muscarinic receptors.
    Sethy VH; Francis JW
    J Pharmacol Exp Ther; 1988 Jul; 246(1):243-8. PubMed ID: 3392656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselectivity of muscarinic receptors in vivo and in vitro for oxotremorine analogues. N-[4-(tertiary amino)-2-butynyl]-5-methyl-2-pyrrolidones.
    Amstutz R; Ringdahl B; Karlén B; Roch M; Jenden DJ
    J Med Chem; 1985 Dec; 28(12):1760-5. PubMed ID: 2933518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123).
    Russell RW; Smith CA; Booth RA; Jenden DJ; Waite JJ
    Psychopharmacology (Berl); 1986; 90(3):308-15. PubMed ID: 3097716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological assessment of a new, potent oxotremorine analogue in mice and rats.
    Resul B; Lewander T; Ringdahl B; Zetterström T; Dahlbom R
    Eur J Pharmacol; 1982 May; 80(2-3):209-15. PubMed ID: 7106176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic acetylcholine receptor alpha5 subunits modulate oxotremorine-induced salivation and tremor.
    Wang N; Orr-Urtreger A; Chapman J; Rabinowitz R; Korczyn AD
    J Neurol Sci; 2004 Jul; 222(1-2):87-91. PubMed ID: 15240201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The central and peripheral effectiveness of two oxotremorine-antagonists determined using oxotremorine-induced tremor and salivation.
    Eicholzer A; Ogren SO
    J Pharm Pharmacol; 1977 Oct; 29(10):609-11. PubMed ID: 21240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylene compounds of potential pharmacological value. XXV. N-(4-pyrrolidino-2-butynyl)-N-alkylcarboxamides.
    Svensson U; Hacksell U; Dahlbom R
    Acta Pharm Suec; 1978; 15(1):67-70. PubMed ID: 645369
    [No Abstract]   [Full Text] [Related]  

  • 20. Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse.
    Ogren SO; Carlsson S; Bartfai T
    Psychopharmacology (Berl); 1985; 86(3):258-64. PubMed ID: 3929296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.